跳至主要内容
临床试验/NCT01680367
NCT01680367已完成不适用

A Comparative Study of Dressings for Split-Thickness Skin Graft Donor Sites.

Ohio State University Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2008年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
2
主要终点
Pain score ranging in value from 0 to 10

研究概览

简要总结

This study is to determine what dressing would work best to heal and keep from hurting, the split-thickness skin graft donor site which will be done as part of the patient's surgical procedure. Currently there is a dressing that is transparent and it is placed on the wound after surgery and wrapped with gauze and an elastic bandage. Two days after the surgery the gauze and elastic bandages are removed and the area is left with the transparent dressing. Sometimes the dressing needs to be changed because it leaks. On the fifth day this dressing is removed and the wound is left open to air. The dressing researchers are studying is a dressing that has been used for different types of wounds, as well as this type of wound. It is applied in the same manner; however, it is left in place until it falls off independently, usually around post-operative (post-op) day 10.

详细描述

PRIMARY OBJECTIVES:

I. Which dressing type and technique is most effective in minimizing pain and inflammation and promoting epithelialization in patients who have had surgery which requires the use of an anterior thigh split-thickness skin graft?

OUTLINE: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive transparent film dressing (otolaryngology service) or Xeroform petroleum gel impregnated gauze dressing (surgical oncology service) after surgery.

ARM II: Patients receive native collagen wound dressing after surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Population of otolaryngological or surgical oncology patients experiencing an autologous split-thickness skin graft as part of their surgical procedure
  • Patients will have a Glasgow Coma score of 15 (or 10 with a tracheostomy)
  • Patient donor sites will be limited to the anterior thigh
  • Patients will be free of documented circulatory deficits, neuropathy, or mental illness which prohibits their ability to independently consent or respond to questions regarding pain
  • Patients will be able to give consent independently
  • Patients will be able to read and write in English

排除标准

  • Patients unable to give independent consent for any reason
  • Skin graft donor sites other than the anterior thigh
  • Patients with a concurrent diagnosis of diabetes, peripheral vascular disease, and/or paresthesias or paralysis of the lower extremities
  • Patients who are unable to complete a self-report pain scale
  • Patients who are prisoners
  • Patients who are known active alcoholics
  • Patients on steroids or other medications known to affect healing

结局指标

主要结局

Pain score ranging in value from 0 to 10

时间窗: Up to 14 days

Initial analyses will include two sample t-tests (or a nonparametric equivalent, if more appropriate) for each day to compare the mean pain scores for each treatment group. The pain score will be evaluated using multiple linear regression, while multiple logistic or polytomous regression will be used for the categorical outcomes.

次要结局

  • Inflammation as measured by the Wound Assessment Inventory (WAI)(Up to 14 days)
  • Distress checklist score(Up to 14 days)
  • Categorical epithelialization assessment(Up to 14 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验